EPZM NASDAQ
Epizyme, Inc.
1W: -0.7%
1M: -0.7%
3M: +214.3%
1Y: -73.2%
3Y: -87.5%
5Y: -88.8%
$1.47
Last traded 2022-08-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$37M
+137.5% ▲
5Y CAGR: +36.1%
Gross Profit
$27M
+151.8% ▲
5Y CAGR: +27.5%
Operating Income
-$227M
-0.7% ▼
Net Income
-$251M
-8.4% ▼
EPS (Diluted)
$-2.49
-8.7% ▼
EBITDA
-$211M
-0.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $10M | $22M | $24M | $16M | $37M |
| YoY Growth | +24.9% | +117.0% | +9.7% | -33.8% | +137.5% |
| Cost of Revenue | $0 | $0 | $0 | $5M | $10M |
| Gross Profit | $10M | $22M | $24M | $11M | $27M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 67.9% | 72.0% |
| R&D Expenses | $110M | $106M | $133M | $111M | $131M |
| SG&A Expenses | $37M | $44M | $68M | $125M | $134M |
| Operating Expenses | $147M | $150M | $201M | $236M | $265M |
| Operating Income | -$137M | -$128M | -$177M | -$225M | -$227M |
| Operating Margin | -1368.4% | -590.3% | -744.3% | -1430.1% | -606.3% |
| Interest Expense | $0 | $0 | $192K | $6M | $24M |
| Income Before Tax | -$135M | -$124M | -$170M | -$232M | -$251M |
| Tax Expense | -$336K | $57K | $58K | $114K | $22K |
| Net Income | -$134M | -$124M | -$170M | -$232M | -$251M |
| Net Margin | -1343.1% | -569.7% | -715.5% | -1470.0% | -671.0% |
| EPS (Diluted) | $-2.18 | $-1.72 | $-1.89 | $-2.29 | $-2.49 |
| EBITDA | -$133M | -$123M | -$169M | -$222M | -$211M |
| Shares Outstanding | 61M | 72M | 90M | 101M | 101M |